Trial Profile
Double-Blind, Randomized, Phase 3, Comparative Study of a New Botulinum Toxin Type A Versus Botox in the Treatment of Essential Blepharospasm
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 14 Oct 2013
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Blepharospasm
- Focus Registrational; Therapeutic Use
- Sponsors Pacific Pharmaceutical
- 14 Oct 2013 New trial record